bf/NASDAQ:PTCT_icon.jpeg

NASDAQ:PTCT

PTC Therapeutics

  • Stock

USD

Last Close

72.59

06/11 21:01

Market Cap

2.44B

Beta: 0.42

Volume Today

1.10M

Avg: 752.35K

PE Ratio

−2.94

PFCF: −5.51

OverviewFinancialsAPI

    Description

    PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on the development of treatments fo...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -3-2.5-2-1.5-1-0.50.52018-03-062019-10-292021-05-042023-02-212024-08-08

    Revenue (Estimate*)

    100M200M300M400M2018-03-062019-10-292021-05-042023-02-212024-08-08

    *Estimate based on analyst consensus